Market Insights MarkNtel Advisors, a leading market research firm, has showed its latest study titled "Molecular Diagnostics (MDx) Point of Care Market", the Molecular Diagnostics (MDx) Point of Care market is projected to register a CAGR of around 15.89% during 2020-25 “In case you missed it, we are currently revising our reports. Click on the below to get the latest research...